drugset / Trial / NCT01696630

Xenon Combined With Intraoperative Thoracic Epidural Analgesia

NCT01696630

Phase 2 Completed 31 enrolled Centre Leon Berard
RandomizedParallel-groupSingle-blindSupportive care

Summary

This is a monocentric study in 2 steps: A safety part to assess the feasibility of using Xenon in association with a thoracic epidural analgesia (TEA) with a sequential recruitment of 3, 6 or 9 patients according to predefined safety rules. The second part will randomly allocated patients (1:1) to receive TEA+Xenon or TEA+Desflurane. 28 patients will be enrolled and followed over 45 days.

Timeline

Start
2012-10
Primary completion
2014-07
Completion
2014-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desflurane Other / unclassified 6.5 %
Subject Xenon Other / unclassified 60 %

Indications